INVESTOR INFORMATION
The service marks displayed on this site, including but not limited to KINDRED®, KINDRED HEALTHCARE®, and the KINDRED HEALTHCARE® logo, are the intellectual property of Kindred Healthcare, Inc. and are protected by applicable law.  Nothing contained on this site should be construed as granting, by implication, estoppel, or otherwise, any license or right to use any service mark displayed on the site without the prior express written permission of Kindred Healthcare, Inc.

 

LTACH Comment Letter
Kindred Healthcare has filed a comment letter with the Centers for Medicare and Medicaid Services regarding the proposed reimbursement changes for long-term acute care hospitals.

KND-PMC Cost Basis Allocation
The cost basis associated with the creation of PharMerica Corporation.

Corporate Profile
An overview of Kindred Healthcare and our three divisions.

Annual Report and CEO Letter
2007 annual report, including the CEO letter to shareholders.

Exec Officers and Board of Directors
A listing of senior management and the board members.

Report of Annual Meeting
Summary of results of annual meeting.

SEC Filings and SEC Form 10-K
Links to our SEC filings, including 10-K, 10-Q and 8-K forms.

Conference Call Replay
Listen to the replay of our quarterly conference calls.

Investor Conferences
Listen to presentations made at investor conferences and view slides.

Code of Conduct
The Code of Conduct for employees

False Claims and Whistleblower Laws
A summary of state Medicaid false claims and whistleblower laws.

Corporate Governance Guidelines
Kindred’s Corporate Governance Guidelines

Committee Composition
A list of the members of our board committees. To read more about any of the committees,
click on the committee names under Committee Charters.

Committee Charters
Click on the committee name below to view the charter.
Audit Committee
Compliance and Quality Committee
Executive Compensation Committee
Nominating and Governance Committee

Press Releases
View Kindred Healthcare’s press releases.

Investor Contact
Contact information for our investors.

Return to Home Page